These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 32004411)

  • 1. Acceptability and Content Validity of Patient-Reported Outcome Measures Considered From the Perspective of Patients With Rheumatoid Arthritis.
    Shaw Y; Zhang C; Bradley M; Simon TA; Schumacher R; McDonald D; Michaud K
    Arthritis Care Res (Hoboken); 2021 Apr; 73(4):510-519. PubMed ID: 32004411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the construct validity and reproducibility of four different types of patient-reported outcome measures (PROMs) in patients with rheumatoid arthritis.
    Renskers L; van Uden RJJC; Huis AMP; Rongen SAA; Teerenstra S; van Riel PLCM
    Clin Rheumatol; 2018 Dec; 37(12):3191-3199. PubMed ID: 30209696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Group cognitive-behavioural programme to reduce the impact of rheumatoid arthritis fatigue: the RAFT RCT with economic and qualitative evaluations.
    Hewlett S; Almeida C; Ambler N; Blair PS; Choy E; Dures E; Hammond A; Hollingworth W; Kadir B; Kirwan J; Plummer Z; Rooke C; Thorn J; Turner N; Pollock J
    Health Technol Assess; 2019 Oct; 23(57):1-130. PubMed ID: 31601357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interplay between patient global assessment, pain, and fatigue and influence of other clinical disease activity measures in patients with active rheumatoid arthritis.
    Egsmose EL; Madsen OR
    Clin Rheumatol; 2015 Jul; 34(7):1187-94. PubMed ID: 25986917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the construct validity and sensitivity to change of the visual analog scale and a modified rating scale as measures of patient global assessment in rheumatoid arthritis.
    Lati C; Guthrie LC; Ward MM
    J Rheumatol; 2010 Apr; 37(4):717-22. PubMed ID: 20194445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct and Indirect Determinants of the Patient Global Assessment in Rheumatoid Arthritis: Differences by Level of Disease Activity.
    Ward MM; Guthrie LC; Dasgupta A
    Arthritis Care Res (Hoboken); 2017 Mar; 69(3):323-329. PubMed ID: 27273981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measuring fatigue in rheumatoid arthritis: a cross-sectional study to evaluate the Bristol Rheumatoid Arthritis Fatigue Multi-Dimensional questionnaire, visual analog scales, and numerical rating scales.
    Nicklin J; Cramp F; Kirwan J; Greenwood R; Urban M; Hewlett S
    Arthritis Care Res (Hoboken); 2010 Nov; 62(11):1559-68. PubMed ID: 20583112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient-reported outcomes from a phase 3 study of baricitinib versus placebo or adalimumab in rheumatoid arthritis: secondary analyses from the RA-BEAM study.
    Keystone EC; Taylor PC; Tanaka Y; Gaich C; DeLozier AM; Dudek A; Zamora JV; Cobos JAC; Rooney T; Bono S; Arora V; Linetzky B; Weinblatt ME
    Ann Rheum Dis; 2017 Nov; 76(11):1853-1861. PubMed ID: 28798049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Re-conceptualizing functional status through experiences of young adults with inflammatory arthritis.
    Carandang K; Vigen CLP; Ortiz E; Pyatak EA
    Rheumatol Int; 2020 Feb; 40(2):273-282. PubMed ID: 31300847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychometric properties of sleep and coping numeric rating scales in rheumatoid arthritis: a subanalysis of an etanercept trial.
    Avila-Ribeiro P; Brault Y; Dougados M; Gossec L
    Clin Exp Rheumatol; 2017; 35(5):786-790. PubMed ID: 28339355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychometric properties of the single-item measure, severity of worst tiredness, in patients with moderately to severely active rheumatoid arthritis.
    Bacci ED; DeLozier AM; Lin CY; Gaich CL; Zhang X; Rooney T; de Bono S; Hoffman R; Wyrwich KW
    Health Qual Life Outcomes; 2017 Dec; 15(1):237. PubMed ID: 29208004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Test-retest reliability of patient global assessment and physician global assessment in rheumatoid arthritis.
    Rohekar G; Pope J
    J Rheumatol; 2009 Oct; 36(10):2178-82. PubMed ID: 19755617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient-reported Outcomes as Predictors of Change in Disease Activity and Disability in Early Rheumatoid Arthritis: Results from the Yorkshire Early Arthritis Register.
    Twigg S; Hensor EMA; Emery P; Tennant A; Morgan AW;
    J Rheumatol; 2017 Sep; 44(9):1331-1340. PubMed ID: 28668806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mapping health assessment questionnaire disability index (HAQ-DI) score, pain visual analog scale (VAS), and disease activity score in 28 joints (DAS28) onto the EuroQol-5D (EQ-5D) utility score with the KORean Observational study Network for Arthritis (KORONA) registry data.
    Kim HL; Kim D; Jang EJ; Lee MY; Song HJ; Park SY; Cho SK; Sung YK; Choi CB; Won S; Bang SY; Cha HS; Choe JY; Chung WT; Hong SJ; Jun JB; Kim J; Kim SK; Kim TH; Kim TJ; Koh E; Lee H; Lee HS; Lee J; Lee SS; Lee SW; Park SH; Shim SC; Yoo DH; Yoon BY; Bae SC; Lee EK
    Rheumatol Int; 2016 Apr; 36(4):505-13. PubMed ID: 26849891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defining Pain That Does Not Interfere With Activities Among Rheumatoid Arthritis Patients.
    Lee YC; Katz P; Quebe A; Sun L; Patel H; Gaich CL; Michaud K
    Arthritis Care Res (Hoboken); 2021 May; 73(5):626-632. PubMed ID: 32058654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of daily electronic patient-reported outcome (PRO) diaries in randomized controlled trials for rheumatoid arthritis: rationale and implementation.
    Bingham CO; Gaich CL; DeLozier AM; Engstrom KD; Naegeli AN; de Bono S; Banerjee P; Taylor PC
    Trials; 2019 Mar; 20(1):182. PubMed ID: 30902094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health-related quality of life: validity, reliability, and responsiveness of SF-36, 15D, EQ-5D [corrected] RAQoL, and HAQ in patients with rheumatoid arthritis.
    Linde L; Sørensen J; Ostergaard M; Hørslev-Petersen K; Hetland ML
    J Rheumatol; 2008 Aug; 35(8):1528-37. PubMed ID: 18484697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of the Rheumatoid Arthritis Symptom Questionnaire (RASQ): a patient reported outcome scale for measuring symptoms of rheumatoid arthritis.
    Banderas B; Skup M; Shields AL; Mazar I; Ganguli A
    Curr Med Res Opin; 2017 Sep; 33(9):1643-1651. PubMed ID: 28574727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tofacitinib with conventional synthetic disease-modifying antirheumatic drugs in Chinese patients with rheumatoid arthritis: Patient-reported outcomes from a Phase 3 randomized controlled trial.
    Li Z; An Y; Su H; Li X; Xu J; Zheng Y; Li G; Kwok K; Wang L; Wu Q
    Int J Rheum Dis; 2018 Feb; 21(2):402-414. PubMed ID: 29314645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Collaboration with patients in the design of patient-reported outcome measures: capturing the experience of fatigue in rheumatoid arthritis.
    Nicklin J; Cramp F; Kirwan J; Urban M; Hewlett S
    Arthritis Care Res (Hoboken); 2010 Nov; 62(11):1552-8. PubMed ID: 20496429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.